home / stock / rnxt / rnxt short
Short Information | RenovoRx Inc. (NASDAQ:RNXT)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 163,725 |
Total Actual Volume | 765,410 |
Short Trends | |
---|---|
Cover Days | 15 |
Short Days | 1 |
No Change Days | 4 |
Averages | |
---|---|
Average Short Volume | 8,186 |
Average Short Percentage | 25.91% |
Is there a RNXT Short Squeeze or Breakout about to happen?
See the RNXT Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
07-19-2024 | $1.22 | $1.16 | $1.22 | $1.1 | 43,478 | 10,568 | 24.31% |
07-18-2024 | $1.3 | $1.19 | $1.31 | $1.15 | 49,231 | 3,499 | 7.11% |
07-17-2024 | $1.27 | $1.27 | $1.3 | $1.26 | 5,741 | 1,414 | 24.63% |
07-16-2024 | $1.28 | $1.25 | $1.28 | $1.22 | 13,175 | 4,972 | 37.74% |
07-15-2024 | $1.3 | $1.28 | $1.31 | $1.262 | 18,519 | 6,672 | 36.03% |
07-12-2024 | $1.15 | $1.2913 | $1.2913 | $1.15 | 97,439 | 31,765 | 32.6% |
07-11-2024 | $1.14 | $1.17 | $1.1974 | $1.14 | 7,670 | 702 | 9.15% |
07-10-2024 | $1.24 | $1.16 | $1.24 | $1.15 | 40,942 | 12,149 | 29.67% |
07-09-2024 | $1.17 | $1.18 | $1.1934 | $1.15 | 9,845 | 2,342 | 23.79% |
07-08-2024 | $1.14 | $1.21 | $1.215 | $1.14 | 39,611 | 5,842 | 14.75% |
07-05-2024 | $1.11 | $1.135 | $1.1911 | $1.11 | 20,131 | 7,552 | 37.51% |
07-03-2024 | $1.11 | $1.12 | $1.149 | $1.11 | 7,360 | 3,816 | 51.85% |
07-02-2024 | $1.11 | $1.13 | $1.15 | $1.11 | 20,913 | 4,881 | 23.34% |
07-01-2024 | $1.15 | $1.15 | $1.16 | $1.112 | 15,320 | 2,389 | 15.59% |
06-28-2024 | $1.23 | $1.13 | $1.23 | $1.13 | 28,690 | 5,874 | 20.47% |
06-27-2024 | $1.2 | $1.16 | $1.2 | $1.11 | 17,535 | 4,879 | 27.82% |
06-26-2024 | $1.11 | $1.13 | $1.18 | $1.11 | 27,621 | 13,489 | 48.84% |
06-25-2024 | $1.09 | $1.13 | $1.2139 | $1.0801 | 61,541 | 17,959 | 29.18% |
06-24-2024 | $1.14 | $1.145 | $1.195 | $1.11 | 28,091 | 4,218 | 15.02% |
06-21-2024 | $1.299 | $1.1 | $1.3 | $1.1 | 212,557 | 18,743 | 8.82% |
News, Short Squeeze, Breakout and More Instantly...
LOS ALTOS, Calif., July 08, 2024 (GLOBE NEWSWIRE) -- RenovoRx, Inc . (“RenovoRx” or the “Company”) (Nasdaq: RNXT) , a clinical-stage biopharmaceutical company developing novel precision oncology therapies based on a local drug-delivery platform, today annou...
LOS ALTOS, Calif., June 26, 2024 (GLOBE NEWSWIRE) -- RenovoRx, Inc . (“RenovoRx” or the “Company”) (Nasdaq: RNXT) , a clinical-stage biopharmaceutical company developing novel precision oncology therapies based on a local drug-delivery platform, announced t...
LOS ALTOS, Calif., June 10, 2024 (GLOBE NEWSWIRE) -- RenovoRx, Inc . (“RenovoRx” or the “Company”) (Nasdaq: RNXT) , a clinical-stage biopharmaceutical company developing novel precision oncology therapies based on a local drug-delivery platform, announced t...